Recurrence patterns of oral leukoplakia after curative surgical resection: Important factors that predict the risk of recurrence and malignancy

Journal of Oral Pathology and Medicine

Volumn 41, Issue 9, 2012, Pages 682-688

  Kuribayashi, Yuri ^a   Tsushima, Fumihiko ^a   Sato, Masaru ^a   Morita, Kei ichi ^a   Omura, Ken ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Epithelial dysplasia; Leukoplakia; Malignant transformation; Oral cancer; Oral precancer; Surgical resection

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DYSPLASIA; FEMALE; GINGIVA; HUMAN; HUMAN TISSUE; LEUKOPLAKIA; MALE; ORAL SURGERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR;

AGE FACTORS; AGED; CELL TRANSFORMATION, NEOPLASTIC; DISEASE-FREE SURVIVAL; EPITHELIUM; FEMALE; FOLLOW-UP STUDIES; FORECASTING; GINGIVAL NEOPLASMS; HUMANS; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TONGUE NEOPLASMS; TREATMENT OUTCOME;

EID: 84866873014     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2012.01167.x     Document Type: Article

References (43)

1. Tradati N, Grigolat R, Calabrese L, et al. Oral leukoplakias: to treat or not? Oral Oncol 1997; 33: 317-21.
2. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol 2006; 42: 461-74.
3. Schepman KP, Van Der Meij EH, Smeele LE, Van Der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from the netherlands. Oral Oncol 1998; 34: 270-5.
4. Ishii J, Fujita K, Komori T. Laser surgery as a treatment for oral leukoplakia. Oral Oncol 2003; 39: 759-69.
5. Lodi G, Porter S. Management of potentially malignant disorders: evidence and critique. J Oral Path Med 2008; 37: 63-9.
6. Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation - a follow-up-study of 257 patients. Cancer 1984; 53: 563-8.
7. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous-cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 321-9.
8. Pindborg JJ, Jolst O, Renstrup G, Roedpete B. Studies in oral leukoplakia - a preliminary report on period prevalence of malignant transformation in leukoplakia based on a follow-up study of 248 patients. J Am Dent Assoc 1968; 76: 767-71.
9. Kramer IRH, Ellabban N, Lee KW. Clinical features and risk of malignant transformation in sub-lingual keratosis. Br Dent J 1978; 144: 171-80.
10. Lind PO. Malignant transformation in oral leukoplakia. Scand J Dent Res 1987; 95: 449-55.
11. Pindborg JJ, Renstrup G. Studies in oral leukoplakias 2. Effect of snuff on oral epithelium. Acta Derm Venereol 1963; 43: 271-6.
12. Banoczy J. Follow-up studies in oral leukoplakia. J Maxillofac Surg 1977; 5: 69-75.
13. Gupta PC, Bhonsle RB, Murti PR, Daftary DK, Mehta FS, Pindborg JJ. An epidemiologic assessment of cancer risk in oral precancerous lesions in india with special reference to nodular leukoplakia. Cancer 1989; 63: 2247-52.
14. Saito T, Sugiura C, Hirai A, et al. High malignant transformation rate of widespread multiple oral leukoplakias. Oral Dis 1999; 5: 15-9.
15. Van Der Waal I, Axell T. Oral leukoplakia: a proposal for uniform reporting. Oral Oncol 2002; 38: 521-6.
16. Lesch CA, Squier CA, Cruchley A, Williams DM, Speight P. The permeability of human oral-mucosa and skin to water. J Dent Res 1989; 68: 1345-9.
17. Pogrel MA. Sub-lingual keratosis and malignant transformation. J Oral Path Med 1979; 8: 176-8.
18. Lee JJ, Hong WK, Hittelman WN, et al. Predicting cancer development in oral leukoplakia: Ten years of translational research. Clin Cancer Res 2000; 6: 1702-10.
19. Pindborg JJ, Daftary DK, Mehta FS. Follow-up-study of 61 oral dysplastic precancerous lesions in indian villagers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1977; 43: 383-90.
20. Vedtofte P, Holmstrup P, Hjorting-Hansen E, Pindborg JJ. Surgical treatment of premalignant lesions of the oral mucosa. Int J Oral Maxillofac Surg 1987; 16: 656-64.
21. Barnes L, Eveson J, Reichert P, Sidransky D, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of the head and neck. Lyon: IARC Press, 2005.
22. Pandey M, Thomas G, Somanathan T, et al. Oral Cancer Screening S: evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, kerala, india. Oral Oncol 2001; 37: 103-9.
23. Thomson PJ, Wylie J. Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management. Int J Oral Maxillofac Surg 2002; 31: 145-53.
24. Goaslind GD, Robertson PB, Mahan CJ, Morrison WW, Olson JV. Thickness of facial gingiva. J Periodontal 1977; 48: 768-71.
25. Yokoyama A, Ohmori T, Makuuchi H, et al. Successful screening for early esophageal cancer in alcoholics using endoscopy and mucosa iodine staining. Cancer 1995; 76: 928-34.
26. Dawsey SM, Fleischer DE, Wang GQ, et al. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in linxian, china. Cancer 1998; 83: 220-31.
27. Froelicher P, Miller G. The european-experience with esophageal cancer limited to the mucosa and submucosa. Gastrointest Endosc 1986; 32: 88-90.
28. Misumi A, Harada K, Murakami A, et al. Role of lugol dye endoscopy in the diagnosis of early esophageal cancer. Endoscopy 1990; 22: 12-6.
29. Mcmahon J, Devine JC, Mccaul JA, Mclellan DR, Farrow A. Use of lugol's iodine in the resection of oral and oropharyngeal squamous cell carcinoma. Br J Oral Maxillofac Surg 2010; 48: 84-7.
30. Amagasa T, Yamashiro M, Uzawa N. Oral premalignant lesions: from a clinical perspective. Int J Clin Oncol 2011; 16: 5-14.
31. Schepman KP, Van Der Meij EH, Smeele LE, Van Der Waal I. Concomitant leukoplakia in patients with oral squamous cell carcinoma. Oral Dis 1999; 5: 206-9.
32. Warnakulasuriya S. Lack of molecular markers to predict malignant potential of oral precancer. J Pathol 2000; 190: 407-9.
33. Huang X, Pateromichelakis S, Hills A, et al. P53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal margins. Clin Cancer Res 2007; 13: 6099-106.
34. Partridge M, Li SR, Pateromichelakis S, et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res 2000; 6: 2718-25.
35. Van Houten VMM, Tabor MP, Van Den Brekel MWM, et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol 2002; 198: 476-86.
36. Partridge M, Gaballah K, Huang XH. Molecular markers for diagnosis and prognosis. Cancer Metastasis Rev 2005; 24: 71-85.
37. Waridel F, Estreicher A, Bron L, et al. Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract. Oncogene 1997; 14: 163-9.
38. Meier JD, Oliver DA, Varvares MA. Surgical margin determination in head and neck oncology: current clinical practice. The results of an international american head and neck society member survey. Head Neck 2005; 27: 952-8.
39. Chiesa F, Boracchi P, Tradati N, et al. Risk of preneoplastic and neoplastic events in operated oral leukoplakias. Eur J Cancer Part B Oral Oncol 1993; 29B: 23-8.
40. Carinci F, Lo Muzio L, Piattelli A, et al. Genetic portrait of mild and severe lingual dysplasia. Oral Oncol 2005; 41: 365-74.
41. Zhang L, Poh CF, Lam WL, et al. Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: molecular evidence of incomplete resection. Oral Oncol 2001; 37: 505-12.
42. Logi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev 2006; 18: CD001829.
43. Mehanna HM, Rattay M, Smith J, Mcconkey CC. Treatment and follow-up oral dysplasia - a systemic review and meta-analysis. Head Neck 2009; 31: 1600-9.